|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19136 |
FusionGeneSummary for KMT2D_HLA-DPA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: KMT2D_HLA-DPA1 | Fusion gene ID: 19136 | Hgene | Tgene | Gene symbol | KMT2D | HLA-DPA1 | Gene ID | 8085 | 3113 |
| Gene name | lysine methyltransferase 2D | major histocompatibility complex, class II, DP alpha 1 | |
| Synonyms | AAD10|ALR|CAGL114|KABUK1|KMS|MLL2|MLL4|TNRC21 | DP(W3)|DP(W4)|HLA-DP1A|HLADP|HLASB|PLT1 | |
| Cytomap | 12q13.12 | 6p21.32 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone-lysine N-methyltransferase 2DALL1-related proteinKabuki make-up syndromeKabuki mental retardation syndromehistone-lysine N-methyltransferase MLL2lysine (K)-specific methyltransferase 2Dlysine N-methyltransferase 2Dmyeloid/lymphoid or mixed- | HLA class II histocompatibility antigen, DP alpha 1 chainHLA DPA1HLA-SB alpha chainMHC class II DP3-alphaMHC class II HLA-DPA1 antigen | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | O14686 | P20036 | |
| Ensembl transtripts involved in fusion gene | ENST00000301067, ENST00000549743, | ENST00000419277, ENST00000428995, ENST00000463066, ENST00000443117, ENST00000551196, ENST00000480521, ENST00000415247, ENST00000484255, ENST00000454805, ENST00000549300, ENST00000475500, ENST00000374808, ENST00000552158, ENST00000488565, ENST00000383224, ENST00000551933, ENST00000474244, ENST00000422504, ENST00000550806, ENST00000494775, ENST00000515317, ENST00000550456, ENST00000502285, | |
| Fusion gene scores | * DoF score | 9 X 9 X 5=405 | 4 X 5 X 1=20 |
| # samples | 11 | 6 | |
| ** MAII score | log2(11/405*10)=-1.88041838424733 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/20*10)=1.58496250072116 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: KMT2D [Title/Abstract] AND HLA-DPA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | KMT2D | GO:0043627 | response to estrogen | 16603732 |
| Tgene | HLA-DPA1 | GO:0071346 | cellular response to interferon-gamma | 8568247 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF931405 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - | ||
| ChiTaRS3.1 | BF931318 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000301067 | ENST00000419277 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000428995 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000463066 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000443117 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000551196 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000480521 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000415247 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000484255 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000454805 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000549300 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000475500 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000374808 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000552158 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000488565 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000383224 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000551933 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000474244 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000422504 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000550806 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000494775 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000515317 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000550456 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000301067 | ENST00000502285 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000419277 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000428995 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000463066 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000443117 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000551196 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000480521 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000415247 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000484255 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000454805 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000549300 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000475500 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000374808 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000552158 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000488565 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000383224 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000551933 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000474244 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000422504 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000550806 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000494775 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000515317 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000550456 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
| intron-intron | ENST00000549743 | ENST00000502285 | KMT2D | chr12 | 49445846 | - | HLA-DPA1 | chr6 | 4517434 | - |
Top |
FusionProtFeatures for KMT2D_HLA-DPA1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| KMT2D | HLA-DPA1 |
| Histone methyltransferase. Methylates 'Lys-4' of histoneH3 (H3K4me). H3K4me represents a specific tag for epigenetictranscriptional activation. Acts as a coactivator for estrogenreceptor by being recruited by ESR1, thereby activatingtranscription. {ECO:0000269|PubMed:16603732,ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KMT2D_HLA-DPA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KMT2D_HLA-DPA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KMT2D_HLA-DPA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for KMT2D_HLA-DPA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | KMT2D | C0796004 | Kabuki make-up syndrome | 5 | CTD_human;ORPHANET;UNIPROT |
| Hgene | KMT2D | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | KMT2D | C0010701 | Phyllodes Tumor | 1 | CTD_human |
| Hgene | KMT2D | C0021364 | Male infertility | 1 | CTD_human |
| Hgene | KMT2D | C0024301 | Lymphoma, Follicular | 1 | CTD_human |
| Hgene | KMT2D | C0036920 | Sezary Syndrome | 1 | CTD_human |
| Hgene | KMT2D | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
| Hgene | KMT2D | C0079772 | T-Cell Lymphoma | 1 | CTD_human |
| Hgene | KMT2D | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Hgene | KMT2D | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Tgene | HLA-DPA1 | C0524909 | Hepatitis B, Chronic | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|